Spirits Company NV Group Eyes 40% Rise In Global Sales Volumes Over 1.5 Yrs
The company is looking at tripling its international distribution footprint by 2026
The company is looking at tripling its international distribution footprint by 2026
The bulk drugs segment of the Indian pharmaceutical sector is expected to see revenue grow at 6 to 8 per cent this fiscal year, helped by higher sales volume stemming from a stable growth outlook, according to a Crisil Ratings report. The bulk drug segment posted 8-10 per cent revenue growth last fiscal, mainly because […]